Examqo

Examqo › Examqo library › Cardiothoracic surgery › Chest wall and thoracic outlet · IMLE

Primary hyperhidrosis and thoracic sympathectomy

Primary focal hyperhidrosis (palms, axillae, face) begins in childhood or adolescence, is symmetrical and disappears during sleep; it is first treated with topical agents, iontophoresis and botulinum toxin, and in selected patients with severe palmar sweating bilateral VATS interruption of the sympathetic chain is done — highly effective, but with a significant risk of compensatory sweating.

Why it matters in the exam

Distinguishing primary from secondary hyperhidrosis is the first step: primary sweating is focal, symmetrical, begins before age 25, does not occur in sleep and sometimes has a family history; generalised, unilateral or nocturnal sweating, or sweating first appearing in an adult, needs work-up for a secondary cause — hyperthyroidism, diabetes, infection, lymphoma, phaeochromocytoma or drugs. Conservative treatment in order: topical aluminium chloride, tap-water iontophoresis (especially effective for the palms), botulinum toxin injections (especially effective for the axillae) and oral anticholinergics such as glycopyrrolate or oxybutynin.

Surgery — division or clipping of the sympathetic chain by bilateral VATS — suits mainly severe palmar sweating that has not responded to conservative treatment. According to the STS consensus (2011) the level is chosen by region: for the palms — R3 or R4 (division over the third or fourth rib); for the axillae — R4 and R5; for facial sweating and blushing — R2, which carries a higher risk of compensatory sweating and Horner syndrome. Palmar success is very high, above 95%. The main and common complication is compensatory sweating of the back, abdomen and thighs, which may be worse than the original problem; it is more common with higher and more extensive division, so it must be explained before surgery. Other complications: Horner syndrome from injury to the stellate ganglion (R1), pneumothorax and bleeding.

Axillary sweating alone is first treated with botulinum toxin or topical treatment, and surgery is kept for selected cases.

Key points

Summary table

RegionMain conservative treatmentSurgical levelNote
PalmsIontophoresis, aluminium chlorideR3 or R4Success above 95%
AxillaeBotulinum toxin, aluminium chlorideR4 and R5Surgery for selected patients
Face and blushingOral anticholinergicsR2High risk of compensatory sweating and Horner
Generalised or nocturnal sweatingLook for a secondary cause—Not for surgery

In the full version for subscribers

The full version is open to subscribers of: Cardiothoracic surgery, General surgery, Dermatology and venereology, Medical licensing exam (IMLE).

Subscriber? Read the full topic Plans and prices 25 free questions

Sources

Sources are given for further reading; the text is written afresh and not copied from them.

Reviewed by the Examqo AI Professor · 2026-11-06. The text may contain errors; when in doubt, check the source.